Vivani Medical Statistics
Total Valuation
Vivani Medical has a market cap or net worth of $66.94 million. The enterprise value is $72.88 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Vivani Medical has 59.24 million shares outstanding. The number of shares has increased by 10.79% in one year.
| Current Share Class | 59.24M |
| Shares Outstanding | 59.24M |
| Shares Change (YoY) | +10.79% |
| Shares Change (QoQ) | +3.16% |
| Owned by Insiders (%) | 37.15% |
| Owned by Institutions (%) | 9.87% |
| Float | 30.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.01 |
| P/TBV Ratio | 5.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 1.63.
| Current Ratio | 2.40 |
| Quick Ratio | 2.13 |
| Debt / Equity | 1.63 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -117.76% and return on invested capital (ROIC) is -39.25%.
| Return on Equity (ROE) | -117.76% |
| Return on Assets (ROA) | -35.03% |
| Return on Invested Capital (ROIC) | -39.25% |
| Return on Capital Employed (ROCE) | -85.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$641,865 |
| Employee Count | 37 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.59% in the last 52 weeks. The beta is 3.32, so Vivani Medical's price volatility has been higher than the market average.
| Beta (5Y) | 3.32 |
| 52-Week Price Change | -38.59% |
| 50-Day Moving Average | 1.05 |
| 200-Day Moving Average | 1.18 |
| Relative Strength Index (RSI) | 64.44 |
| Average Volume (20 Days) | 53,615 |
Short Selling Information
The latest short interest is 316,537, so 0.53% of the outstanding shares have been sold short.
| Short Interest | 316,537 |
| Short Previous Month | 348,233 |
| Short % of Shares Out | 0.53% |
| Short % of Float | 1.02% |
| Short Ratio (days to cover) | 3.60 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -25.01M |
| Pretax Income | -25.37M |
| Net Income | -23.75M |
| EBITDA | -24.60M |
| EBIT | -25.01M |
| Earnings Per Share (EPS) | -$0.42 |
Full Income StatementBalance Sheet
The company has $13.01 million in cash and $18.94 million in debt, giving a net cash position of -$5.93 million or -$0.10 per share.
| Cash & Cash Equivalents | 13.01M |
| Total Debt | 18.94M |
| Net Cash | -5.93M |
| Net Cash Per Share | -$0.10 |
| Equity (Book Value) | 11.62M |
| Book Value Per Share | 196.21 |
| Working Capital | 8.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$21.44 million and capital expenditures -$379,000, giving a free cash flow of -$21.82 million.
| Operating Cash Flow | -21.44M |
| Capital Expenditures | -379,000 |
| Free Cash Flow | -21.82M |
| FCF Per Share | -$0.37 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |